UROBIOME THERAPEUTICS

Serial Number 88303231
602

Registration Progress

Application Filed
Feb 15, 2019
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

UROBIOME THERAPEUTICS

Basic Information

Serial Number
88303231
Filing Date
February 15, 2019
Abandonment Date
October 22, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Nov 2, 2020
Classes
042

Rights Holder

Urobiome Therapeutics, LLC.

16
Address
1209 Orange Street
Wilmington, DE 19801

Ownership History

Urobiome Therapeutics, LLC.

Original Applicant
16
Wilmington, DE

Legal Representation

Attorney
Gayle L. Strong

USPTO Deadlines

All Deadlines Cleared

All 9 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Nov 2, 2020 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Nov 2, 2020 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Apr 21, 2020 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 21, 2020 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 21, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 31, 2020 ALIE A ASSIGNED TO LIE Loading...
Mar 31, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 31, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 23, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 25, 2019 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Oct 24, 2019 IUAA P USE AMENDMENT ACCEPTED Loading...
Oct 24, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 24, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 24, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 23, 2019 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2019 IUAF S USE AMENDMENT FILED Loading...
Oct 23, 2019 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Oct 22, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 22, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 22, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 22, 2019 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Oct 17, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 17, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 3, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 3, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 3, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 29, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical products development; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
First Use Anywhere: May 31, 2019
First Use in Commerce: May 31, 2019

Classification

International Classes
042